Content area

Abstract

Indaptus Therapeutics Inc (INDP) - Pharmaceuticals and Healthcare Product Pipeline

Summary

Indaptus Therapeutics Inc (Intec Pharma) is a biopharmaceutical company that develops drugs based on its proprietary Accordion Pill technology. The company’s product pipeline includes AP-CD/LD, a gastric-retentive drug used for treating Parkinson’s disease; AP-THC and AP-CBD, cannabinoid treatments for multiple pain indications such as low back pain, neuropathic pain and fibromyalgia.

This report provides outline on pipeline products by Number of Pipeline Products by Therapy Area, Indication, development stage and Partnered/Out-Licensed Products.

This report is built using information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Details

1007133
Company / organization
Title
Indaptus Therapeutics Inc (INDP)
Publication title
Number of pages
47
Publication year
2025
Publication date
2025
Publisher
GlobalData plc
Place of publication
London
Country of publication
United Kingdom
Publication subject
Source type
Report
Language of publication
English
Document type
Company Profile
Document feature
Tables; Graphs; Company description; Company financials; Company competitors; Company SWOT
ProQuest document ID
2453677352
Document URL
https://www.proquest.com/reports/indaptus-therapeutics-inc-indp/docview/2453677352/se-2?accountid=208611
Copyright
Copyright GlobalData plc 2025
Last updated
2025-08-25
Database
ProQuest One Academic